BETA-LACTAMASE EXPRESSION AND CROSS-RESISTANCE TO BETA-LACTAM ANTIBIOTICS IN A NOSOCOMIAL POPULATION OF ENTEROBACTER

被引:5
|
作者
STEFFEE, CH
WASILAUSKAS, BL
机构
[1] Department of Pathology, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC
关键词
BETA-LACTAMASE; ENTEROBACTER-CLOACAE; ENTEROBACTER-AEROGENES;
D O I
10.1159/000239016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study sought to quantitatively describe the spectrum of constitutive and inducible beta-lactamase activity present in a tertiary care center's population of Enterobacter species. Beta-Lactamase activity in the absence and presence of 2 recognized beta-lactamase-inducing antibiotics, cefoxitin and imipenem, was measured. The Enterobacter cloacae (n = 35) population was strikingly bimodal, expressing 'all-or-none' cross-resistance to beta-lactams (except imipenem) corresponding to the baseline level of beta-lactamase expression. E. aerogenes (n = 14) displayed a less dichotomous pattern of resistance, and MICs of beta-lactam antibiotics were less strongly related to the magnitude of enzyme activity. We conclude that our nosocomial population of E. cloacae, like strains rendered resistant to beta-lactams in vitro, is largely dependent upon beta-lactamase as a mechanism of this resistance. Furthermore, we document the presence of a large subpopulation of beta-lactam-susceptible isolates possessing inducible beta-lactamase and therefore subject to selection for enzyme derepression.
引用
收藏
页码:291 / 296
页数:6
相关论文
共 50 条
  • [21] STAPHYLOCOCCAL BETA-LACTAMASE AND EFFICACY OF BETA-LACTAM ANTIBIOTICS - INVITRO AND INVIVO EVALUATION
    CHAPMAN, SW
    STEIGBIGEL, RT
    JOURNAL OF INFECTIOUS DISEASES, 1983, 147 (06): : 1078 - 1089
  • [22] IODOMETRIC ASSAY METHOD FOR BETA-LACTAMASE WITH VARIOUS BETA-LACTAM ANTIBIOTICS AS SUBSTRATES
    SAWAI, T
    TAKAHASHI, I
    YAMAGISHI, S
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1978, 13 (06) : 910 - 913
  • [23] MUTUAL PRO-DRUGS OF BETA-LACTAM ANTIBIOTICS AND BETA-LACTAMASE INHIBITORS
    BALTZER, B
    BINDERUP, E
    VONDAEHNE, W
    GODTFREDSEN, WO
    HANSEN, K
    NIELSEN, B
    SORENSEN, H
    VANGEDAL, S
    JOURNAL OF ANTIBIOTICS, 1980, 33 (10): : 1183 - 1192
  • [24] SUSCEPTIBILITY OF ANAEROBIC-BACTERIA TO BETA-LACTAM ANTIBIOTICS AND BETA-LACTAMASE PRODUCTION
    ALDRIDGE, KE
    SANDERS, CV
    LEWIS, AC
    MARIER, RL
    JOURNAL OF MEDICAL MICROBIOLOGY, 1983, 16 (01) : 75 - 82
  • [25] ISOLATION OF ENTEROBACTER-AEROGENES SUSCEPTIBLE TO BETA-LACTAM ANTIBIOTICS DESPITE HIGH-LEVEL BETA-LACTAMASE PRODUCTION
    MELLENCAMP, MA
    ROCCAFORTE, JS
    PREHEIM, LC
    SANDERS, CC
    ANENE, CA
    BITTNER, MJ
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1990, 9 (11) : 827 - 830
  • [26] PSEUDOMONAS-PSEUDOMALLEI RESISTANCE TO BETA-LACTAM ANTIBIOTICS DUE TO ALTERATIONS IN THE CHROMOSOMALLY ENCODED BETA-LACTAMASE
    GODFREY, AJ
    WONG, S
    DANCE, DAB
    CHAOWAGUL, W
    BRYAN, LE
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (08) : 1635 - 1640
  • [27] Biochip for the Simultaneous Identification of Beta-Lactamase and Carbapenemase Genes Conferring Bacterial Resistance to Beta-Lactam Antibiotics
    Rubtsova, M. Yu.
    Ulyashova, M. M.
    Pobolelova, Yu. I.
    Presnova, G. V.
    Egorov, A. M.
    APPLIED BIOCHEMISTRY AND MICROBIOLOGY, 2020, 56 (02) : 130 - 140
  • [28] Biochip for the Simultaneous Identification of Beta-Lactamase and Carbapenemase Genes Conferring Bacterial Resistance to Beta-Lactam Antibiotics
    M. Yu. Rubtsova
    M. M. Ulyashova
    Yu. I. Pobolelova
    G. V. Presnova
    A. M. Egorov
    Applied Biochemistry and Microbiology, 2020, 56 : 130 - 140
  • [29] BETA-LACTAMASE ALTERATION OF BETA-LACTAM INHIBITORY ZONES
    TAUSK, F
    STRATTON, CW
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1987, 6 (04) : 474 - 476
  • [30] Ureidopenicillins and beta-lactam/beta-lactamase inhibitor combinations
    Bush, LM
    Johnson, CC
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2000, 14 (02) : 409 - +